📰 Material Command News
Page 6 - Material Command News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Material Command. Real-time updates on events, politics, business and more.
November 9, 2023
Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data analysis completion expected before year-end.PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorptio
October 5, 2023
PRINCETON, N.J., Oct. 05, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification,...
October 5, 2023
PRINCETON, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
September 19, 2023
PRINCETON, N.J., Sept. 19, 2023 -- CytoSorbents Corporation , a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly...
August 22, 2023
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
July 19, 2023
PRINCETON, N.J., July 19, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its...
July 19, 2023
/PRNewswire/ -- DCS Corporation has been awarded a subcontract by Odyssey Systems Consulting Group, Ltd. to support the Air Force Life Cycle Management Center...
July 11, 2023
PRINCETON, N.J., July 11, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its...
July 7, 2023
PRINCETON, N.J., July 07, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its...
July 7, 2023
PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its